186 related articles for article (PubMed ID: 7916524)
1. Compliance, quality assurance and standards for relapse prevention in schizophrenia.
Kissling W
Acta Psychiatr Scand Suppl; 1994; 382():16-24. PubMed ID: 7916524
[TBL] [Abstract][Full Text] [Related]
2. The current unsatisfactory state of relapse prevention in schizophrenic psychoses--suggestions for improvement.
Kissling W
Clin Neuropharmacol; 1991; 14 Suppl 2():S33-44. PubMed ID: 1684309
[TBL] [Abstract][Full Text] [Related]
3. Oral versus depot administration of neuroleptics in relapse prevention.
Gerlach J
Acta Psychiatr Scand Suppl; 1994; 382():28-32. PubMed ID: 7916526
[TBL] [Abstract][Full Text] [Related]
4. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Hogarty GE
J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant schizophrenia--the role of clozapine.
Meltzer HY
Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
[TBL] [Abstract][Full Text] [Related]
6. The routine use of atypical antipsychotic agents: maintenance treatment.
Kinon BJ
J Clin Psychiatry; 1998; 59 Suppl 19():18-22. PubMed ID: 9847048
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
8. Good medical practice in antipsychotic pharmacotherapy.
Peuskens J
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
[TBL] [Abstract][Full Text] [Related]
9. Strategies for enhancing drug therapy of schizophrenia.
Schooler NR; Levine J
Am J Psychother; 1983 Oct; 37(4):521-32. PubMed ID: 6140869
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of relapse in schizophrenia is discontinued too soon. Many colleagues make this mistake!].
Seemann U; Kissling W
MMW Fortschr Med; 2000 Feb; 142(5):34-8. PubMed ID: 10715937
[TBL] [Abstract][Full Text] [Related]
12. The natural course of schizophrenia and effective maintenance drug treatment.
Davis JM; Andriukaitis S
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
McGrath JJ; Soares KV
Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Soares-Weiser K; Rathbone J
Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
[TBL] [Abstract][Full Text] [Related]
15. How high is the relapse rate in schizophrenia?
Johnstone EC; Geddes J
Acta Psychiatr Scand Suppl; 1994; 382():6-10. PubMed ID: 7916528
[TBL] [Abstract][Full Text] [Related]
16. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics.
Csernansky JG; Schuchart EK
CNS Drugs; 2002; 16(7):473-84. PubMed ID: 12056922
[TBL] [Abstract][Full Text] [Related]
17. Management strategies for the treatment of schizophrenia.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing relapse in the long-term course of schizophrenia.
Ayuso-Gutiérrez JL; del Río Vega JM
Schizophr Res; 1997 Dec; 28(2-3):199-206. PubMed ID: 9468354
[TBL] [Abstract][Full Text] [Related]
19. Prevention of relapse in chronic schizophrenic patients.
Hogarty GE
J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
[TBL] [Abstract][Full Text] [Related]
20. [Compliance in therapy of schizophrenic patients with neuroleptics--an overview].
Mayer C; Soyka M
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):217-22. PubMed ID: 1353747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
